AU Patent
AU2008211124A1 — Reduced irritant enema for the treatment of Inflammatory Bowel Disease (IBD)
Assigned to Alaven Pharmaceutical LLC · Expires 2008-08-07 · 18y expired
What this patent protects
Patent listed against mesalamine.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.